Premium
Mephedrone: use, subjective effects and health risks
Author(s) -
Winstock Adam,
Mitcheson Luke,
Ramsey John,
Davies Susannah,
Puchnarewicz Malgorzata,
Marsden John
Publication year - 2011
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/j.1360-0443.2011.03502.x
Subject(s) - mephedrone , euphoriant , ecstasy , mdma , stimulant , psychology , psychiatry , medicine , drug , clinical psychology
Aims To assess the patterns of use, subjective effect profile and dependence liability of mephedrone, supported by corroborative urine toxicology. Design Cross‐sectional structured telephone interview. Setting UK‐based drug users associated with the dance music scene. Participants A total of 100 mephedrone users, recruited through their involvement with the dance music scene. Measurements Assessment of pattern of use, acute and after effects, DSM dependence criteria and gas chromatography‐mass spectrometry urinalysis. Findings Mephedrone consumption results in typical stimulant‐related subjective effects: euphoria, increased concentration, talkativeness, urge to move, empathy, jaw clenching, reduced appetite and insomnia. Thirty per cent of the sample potentially met criteria for DSM‐IV dependence and there was evidence of a strong compulsion to use the drug (47% had used the drug for 2 or more consecutive days). Self‐reported recent consumption of mephedrone was confirmed by toxicological analysis in all of the 14 participants who submitted a urine sample. Conclusion Mephedrone has a high abuse and health risk liability, with increased tolerance, impaired control and a compulsion to use, the predominant reported dependence symptoms.